Company / AR per Share
Anika Therapeutics, Inc. AR per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$1.64
FY2025
5-year range
$1.61 / $2.40
FY2021-FY2025
Trend
+2.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
AR per Share returned to growth in FY2025 after 2 years of decline, reaching $1.64.
Based on SEC 10-K filings.
1.64 in FY2025 with a 5-year CAGR of +0.4%.
Declined from $1.80 to $1.64 over the past 2 years.
AR per Share over time
Growth rates
- 3-Year CAGR
- -11.8%
- 5-Year CAGR
- +0.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, ar per share increased 2.1% year-over-year.
- Peak ar per share was recorded in FY2022.
- Lowest ar per share in the period was in FY2018.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.64 | +2.1% |
| FY2024 | $1.61 | -10.7% |
| FY2023 | $1.80 | -24.8% |
| FY2022 | $2.40 | +15.1% |
| FY2021 | $2.08 | +29.1% |
| FY2020 | $1.61 | -0.7% |
| FY2019 | $1.62 | +14.8% |
| FY2018 | $1.41 | -13.2% |
| FY2017 | $1.63 | -11.3% |
| FY2016 | $1.84 | +25.9% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026